Dataset from Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects With Primary Immunodeficiency Diseases
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009437
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to acquire additional data on safety, tolerability and
immunogenicity of HyQvia in pediatric (age two to <18 years) patients with Primary
Immunodeficiency Diseases (PIDD)
创建时间：
2024-11-26
